Stewart GD, Van Neste L, Delvenne P, Delrée P, Delga A, McNeill SA, et al. Clinical utility of an epigenetic assay to detect occult prostate cancer in histopathologically negative biopsies: results of the MATLOC study. J Urol 2013 Mar;189(3):1110-6 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/22999998.
Compare quality appraisals for each clinical question
- In men who have been referred with suspected prostate cancer, what are the prognostic factors that determine the need for further investigation following a prior negative biopsy?